natgillin/translations-raw huggingface dataset:
Care should be taken to ensure that the contents of the spot-on applicator, or the applied dose, do not come into contact with the eyes of the cat to be treated and/or any other animals. 
Pazite, da vsebina aplikatorja ali uporabljenega odmerka ne pride v oči zdravljene mačke ali katere koli druge živali.
Once bound to these receptors, the full agonist action of repeated excitatory impulses kills the insect. 
Po vezavi na te receptorje se sproži agonistična reakcija, večkratni ekscitatorni impulzi insekt ubijejo.
The impact of shampooing on the efficacy of the veterinary medicinal product has not been evaluated. 
Učinek šamponiranja na učinkovitost zdravila ni bil ocenjen.
Do not contaminate ponds, waterways or ditches with the veterinary medicinal product or with used containers. 
Ne onesnažujte ribnikov, vodotokov ali jarkov z zdravilom za uporabo v veterinarski medicini ali z uporabljenim vsebnikom.
• Used applicators should be disposed of immediately and not left within the sight or reach of children. 
• Uporabljene aplikatorje takoj zavrzite in jih ne puščajte na mestu, ki je vidno ali dosegljivo otrokom.
SPECIAL WARNING(S), IF NECESSARY Avoid contact of the product with your skin, eyes or mouth. 
POSEBNO(A) OPOZORILO(A), ČE JE/SO POTREBNO(A) Izogibajte se stiku zdravila s kožo, očmi ali usti.
• Wash hands thoroughly and immediately after use. 
• Takoj po uporabi zdravila si temeljito umijte roke.
Treatment and prevention of flea infestations (Ctenocephalides felis) on cats. 
Zdravljenje in preprečevanje bolhavosti (Ctenocephalides felis) pri mačkah.
MARKETING AUTHORISATION NUMBER(S) EU/2/14/165/001-004 
ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/14/165/001-004
Dinotefuran has a low affinity for mammalian acetylcholine receptor sites. 
Dinotefuran ima nizko afiniteto do sesalskih acetilholinskih receptorjev.
The use in cats younger than 7 weeks or weighing less than 0.6 kg is not recommended. 
Uporaba pri mačkah, ki so mlajše od 7 tednov ali tehtajo manj od 0,6 kg, ni priporočljiva.
In laboratory species, after intra-peritoneal administration, dinotefuran is rapidly eliminated as the unchanged parent molecule mainly via the urine. 
V laboratorijskih živalskih vrstah se dinotefuran po intraperiotnealni aplikaciji hitro izloči kot nespremenjena matična molekula, v glavnem preko urina.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, other ectoparasiticides for topical use. 
Farmakoterapevtska skupina: Antiparazitiki, insekticidi in repelenti, druge učinkovine proti ektoparazitom za lokalno zdravljenje
Colourless to pale yellow solution. 
Brezbarvna do bledo rumena raztopina.
• In case of accidental spillage onto skin, wash off immediately with soap and water. 
• V primeru nenamernega razlitja po koži, takoj sperite z milom in vodo.
Do not use this veterinary medicinal product after the expiry date which is stated on the carton and spot-on applicator after “EXP”. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na kartonski škatli in aplikatorju kožnega nanosa (poleg oznake »EXP«).
6.5 Nature and composition of immediate packaging Spot-on applicator made of a multilayered complex of aluminium and polyethylene (PE) with a head made of HDPE, top-sealed with a liner complex (aluminium/polyester/sealable PE layer). 
Aplikator kožnega nanosa iz večslojnega kompleksa aluminija in polietilena (PE) z glavo, izdelano iz HDPE; vrh je zatesnjen z linearnim kompleksom (aluminij/poliester/zatesnitveni PE sloj).
It acts through contact, by mimicking the juvenile hormone which regulates the moulting of insects from one life stage to the next. 
Deluje s stikom, tako, da oponaša juvenilni hormon, ki uravnava levitev insekta iz ene v drugo razvojno stopnjo.
People with known hypersensitivity to dinotefuran, pyriproxyfen or dimethyl sulfoxide should avoid contact with this veterinary medicinal product. 
Osebe z znano preobčutljivostjo na dinotefuran, piriproksifen ali dimetilsulfoksid naj se izogibajo stiku z zdravilom.
The veterinary medicinal product is irritating to the eyes and skin. 
To zdravilo je dražljivo za oči in kožo.
Do not use in cats or kittens weighing less than 0.6 kg. Do not use in cases of hypersensitivity to the active substances or to any of the excipients. 
Ne uporabite pri mačkah ali mladičih mačk, ki so lažji od 0,6 kg. Ne uporabite v primerih preobčutljivosti na učinkovine ali na katerokoli pomožno snov.
Care should be taken to apply the dose to an area where the animal cannot lick it off (see section 4.9), and to ensure that animals do not groom each other immediately following treatment. 
Paziti je treba, da se odmerek nanese na mesto, kjer ga žival ne more polizati (glej poglavje 4.9), in preprečiti, da bi se živali lizale med seboj takoj po nanosu zdravila.
Fleas are killed by dinotefuran within 2 hours after treatment or infestation. 
Dinotefuran bolhe ubije v 3 urah po zdravljenju ali infestaciji.
Spot-on use for external application to the skin. 
Kožni nanos za zunanjo uporabo na koži.
After oral administration, pyriproxyfen is rapidly metabolized, principally by hydroxylation, and eliminated mainly in the faeces, and to a lesser extent in the urine. 
Po peroralni uporabi se piriproksifen hitro presnovi, predvsem s hidroksilacijo, in v glavnem izloči z blatom in v manjši meri z urinom.
The veterinary medicinal product kills fleas within 2 hours after application of the product or 2 hours after infestation of the treated animal. 
Zdravilo za uporabo v veterinarski medicini ubije bolhe v 2 urah po nanosu ali 2 uri po okužbi zdravljene živali.
In case of suspicion of dermatitis (itch and skin irritation), seek for veterinary advice. 
V primeru suma na dermatitis (srbenje in draženje kože) se posvetujte z veterinarjem.
Dogs in the household should only be treated with a veterinary medicinal product authorised for use in that species. 
Pse v istem gospodinjstvu je treba tretirati samo z zdravilom za uporabo v veterinarski medicini, ki je odobreno za uporabo pri psih.
If skin or if eye irritation persists, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. 
Če draženje kože ali oči vztraja dalj časa ali če pride do nenamernega zaužitja, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
The two active ingredients in the product spread over the body surface of the cat within the first day after application. 
Obe učinkovini v zdravilu za uporabo v veterinarski medicini se porazdelita po telesni površini mačke v prvem dnevu po nanosu.
Pyriproxyfen also blocks the development of juvenile stages (larvae and early (pharate) pupae) into adult emergence. 
Piriproksifen prav tako zavre razvoj juvenilnih stopenj (larv in zgodnjih pup) v odrasle insekte.
Transient cosmetic effects such as wet hair and a white dry residue may occur at the application site very rarely and may persist up to 7 days; however, these effects are usually not noticeable after 48 hours. 
Na mestu nanosa se lahko zelo redko pojavijo prehodni kozmetični učinki, kot so mokra dlaka in beli suhi ostanki, ki lahko ostanejo do 7 dni; vendar ti učinki navadno niso več opazni po 48 urah.
This will pierce the seal. 
Tako boste prebodli zapiralo.
This veterinary medicine kills fleas (Ctenocephalides felis) on infested cats and prevents further infestations for one month. 
Zdravilo za uporabo v veterinarski medicini ubija bolhe (Ctenocephalidec felis) na okuženih mačkah in preprečuje nadaljnjo okužbo še en mesec po nanosu.
Following topical application, the two actives rapidly distribute over the body surface of the animal within the first day and were still measurable in different zones of the hair coat one month after treatment. 
Po kožnem nanosu se v prvem dnevu obe učinkovini hitro razporedita po površini telesa živali in sta v različnih predelih dlake bili izmerjeni še en mesec po nanosu.
All cats within the household should be treated. 
Potreben je nanos zdravila pri vseh mačkah v gospodinjstvu.
Use one spot-on applicator for one administration on one cat only. 
Uporabite en aplikator kožnega nanosa za eno odmerjanje, pri eni mački.
Pyriproxyfen stops the flea life cycle by both inducing premature oviposition and also suppressing yolk deposition in flea eggs, leading to the production of infertile eggs. 
Piriproksifen prekine življenjski cikel bolhe tako, da sproži prezgodnje odlaganje jajčec in zavre nabiranje rumenjaka v jajčecu bolhe, kar vodi do nastanka neplodnega jajčeca.
Slight scales, transient erythema and alopecia can be observed in rare cases, which usually disappear spontaneously without treatment. 
V redkih primerih je mogoče opaziti rahlo luščenje, prehodni eritem in alopecijo, ki običajno izginejo spontano brez zdravljenja.
The safety of the product has not been established in cats younger than 7 weeks or weighing less than 0.6 kg (see section “Contraindications”). 
Varnost zdravila pri mačkah, mlajših od 7 tednov ali lažjih od 0,6 kg ni bila ugotovljena (glejte poglavje »Kontraindikacije«).
Care should be taken to apply the dose to an area where the animal cannot lick it off (as described in section "Advice on correct administration"), and to ensure that animals do not groom each other immediately following treatment. 
Paziti je treba, da se odmerek nanese na mesto, kjer ga žival ne more polizati (glej poglavje 9 »Nasvet o pravilni uporabi zdravila«), in preprečiti, da bi se živali lizale med seboj takoj po nanosu zdravila.
Care should be taken to apply the veterinary medicine only onto intact (undamaged) cat's skin. 
Paziti je treba, da zdravilo za uporabo v veterinarski medicini nanesete le na nepoškodovano kožo mačke.
Dimethyl sulfoxide 
Seznam pomožnih snovi dimetilsulfoksid
MANUFACTURER'S BATCH NUMBER Lot: 
PROIZVAJALČEVA ŠTEVILKA SERIJE Lot
Treatment and prevention of infestations with fleas for 1 month. 
Zdravljenje in preprečevanje infestacij z bolhami 1 mesec po nanosu.
No studies have been performed in sick or convalescent cats, therefore use in these cats should be based on the benefit-risk assessment of a veterinarian. 
Ni podatkov o varnosti ter učinkovitosti tega zdravila pri bolnih mačkah ali mačkah med okrevanjem po bolezni, zato mora uporaba zdravila pri teh mačkah temeljiti na oceni razmerja korist-tveganje odgovornega veterinarja.
After accidental ingestion of the product, transient reactions such as salivation, abnormal faeces and emesis may occur, however these should resolve without treatment within 4 hours. 
Po nenamernem zaužitju, se lahko pojavijo prehodne reakcije kot so slinjenje, neobičajno blato in bruhanje, ki pa brez zdravljenja izginejo v 4 urah.
It is therefore recommended to treat the animal in the evening. 
Zdravilo je priporočljivo nanesti zvečer.
6.6 Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. 
Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi zahtevami.
ADVICE ON CORRECT ADMINISTRATION How to apply: 
NASVET O PRAVILNI UPORABI ZDRAVILA
The need to re-treat cats which are likely to be re-infested, and the time interval between such treatments, should be based on an assessment by a veterinarian. 
Potrebo po ponovitvi odmerka zdravila pri mačkah, ki so podvržene ponovni okužbi in časovni interval med odmerki naj določi odgovorni veterinar.
NAME OF THE VETERINARY MEDICINAL PRODUCT Vectra Felis spot-on 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Vectra Felis kožni nanos
Treated animals must not be handled for at least 8 hours after application of the product. 
Stiku z zdravljeno živaljo se izogibajte vsaj osem ur po nanosu zdravila.
EXPIRY DATE Once opened, use immediately. 
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA Po odprtju uporabite takoj.
Following a single administration, the veterinary medicinal product will prevent flea infestation for one month and prevent further flea multiplication by inhibiting flea emergence in the environment of the cat for 3 months. 
Po enkratnem nanosu bo zdravilo za uporabo v veterinarski medicini preprečevalo okužbo z bolhami en mesec in bo preprečevalo nadaljnje razmnoževanje bolh tako, da bo zaviralo pojavljanje bolh v okolju mačke tri mesece.
Laboratory studies with each of the components, dinotefuran or pyriproxyfen, in rats and rabbits have not produced any evidence of maternotoxic, teratogenic or foetotoxic effects. 
Z laboratorijskimi študijami posameznih sestavin (dinotefuran oziroma piriproksifen) na podganah in kuncih niso bili dokazani toksični učinki na mater, teratogeni ali fetotoksični učinki.
Other application site disorders such as erythema, pruritus, lesions and inflammation may occur very rarely. 
Zelo redko se lahko pojavijo druge motnje na mestu nanosa, kot so eritem, pruritus, lezije in vnetje.
Fleas can infest the cat's basket, bedding and regular resting areas such as carpets and soft furnishings. 
Bolhe se lahko zaredijo tudi v košari živali, odejah in na drugih mestih, kjer živali običajno ležijo, kot so preproge in oblazinjeno pohištvo.
The parasite comes in contact with the treated cat and is then killed. 
Zdravilo ubije zajedavce, ki pridejo v stik z zdravljeno mačko.
Apply the veterinary medicinal product slowly with the tip of the applicator on the skin. 
Zdravilo počasi nanašajte s konico aplikatorja na koži.
Method and route of administration: Spot-on use. 
Način in pot uporabe: Nanos na kožo.
METHOD AND ROUTE(S) OF ADMINISTRATION See package leaflet for instructions for use. 
NAČIN IN POT(I) UPORABE Pred uporabo preberite navodilo za uporabo.
The safety of the veterinary medicinal product has not been established during pregnancy and lactation in adult female cats. 
Varnost zdravila za uporabo v veterinarski medicini v obdobju brejosti in laktacije ni bila ugotovljena.
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Veterinary medicinal product not subject to prescription. 
B POGOJI TER OMEJITVE GLEDE OSKRBE IN UPORABE Brez Rp-Vet.
It also prevents the multiplication of fleas, by inhibiting immature flea emergence in the cat's environment, for 3 months. 
Prav tako preprečuje razmnoževanje bolh tako, da zavira pojavljanje nezrelih bolh v okolju mačke tri mesece.
Dinotefuran………………….. 423 mg Pyriproxyfen………………… 42.3 mg For the full list of excipients, see section 6.1. 
Vsak 0,9 ml aplikator kožnega nanosa vsebuje: dinotefuran…………………..423 mg piriproksifen…………………..42,3 mg Za celoten seznam pomožnih snovi, glejte poglavje 6.1.
Cardboard box of 1, 3, 4, 6, 12 or 24 spot-on applicator(s). 
Kartonska škatla z 1, 3, 4, 6, 12, ali 24 aplikatorji kožnega nanosa.
Pack sizes: Cardboard box of 1, 3, 4, 6, 12 or 24 spot-on applicator(s). 
Velikost pakiranja: Kartonska škatla z 1, 3, 4, 6, 12 ali 24 aplikatorji kožnega nanosa.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Spot-on applicator 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box of 1, 3, 4, 6, 12 and 24 spot-on applicators 
PODATKI NA ZUNANJI OVOJNINI Kartonska škatla z 1, 3, 4, 6, 12 in 24 aplikatorjev kožnega nanosa
Colourless to pale yellow spot-on solution. 
Brezbarvna do bledo rumena raztopina za kožni nanos.
NAME OF THE VETERINARY MEDICINAL PRODUCT Vectra Felis 423 mg/42.3 mg spot-on solution for cats dinotefuran/pyriproxyfen 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Vectra Felis 423 mg/42,3 mg kožni nanos, raztopina za mačke dinotefuran/piriproksifen
(The minimum recommended dose is 42.3 mg dinotefuran/kg bodyweight and 4.23 mg pyriproxyfen/kg bodyweight. 
(Najnižji priporočeni odmerek je 42,3 mg dinotefurana/kg telesne mase in 4,23 mg piriproksifena/kg telesne mase.
No clinically important adverse reactions were observed in healthy kittens aged 7 weeks or more, topically treated 7 times at 2 week intervals and with up to 4 times the highest recommended dose except transient oedema or dry skin at the application site. 
Pri dajanju do 4-krat večjega odmerka od najvišjega priporočenega, topikalno, 7-krat v dvotedenskih razmikih, ni bilo pri zdravih mačjih mladičih, starejših od 7 tednov, opaziti klinično pomembnih neželenih učinkov, razen prehodnega edema ali suhe kože na mestu nanosa.
It also prevents the multiplication of fleas by inhibiting flea emergence in the environment of the cat for 3 months. 
Prav tako preprečuje razmnoževanje bolh tako, da tri mesece zavira pojavljanje bolh v okolju mačke.
Avoid superficial application to the cat's hair. 
Izogibajte se nanosu zdravila na mačjo dlako.
Prevention of flea multiplication for 3 months. 
Preprečevanje razmnoževanja bolh 3 mesece po nanosu.
1 spot-on applicator 3 spot-on applicators 4 spot-on applicators 6 spot-on applicators 12 spot-on applicators 24 spot-on applicators 
1 aplikator kožnega nanosa 3 aplikatorji kožnega nanosa 4 aplikatorji kožnega nanosa 6 aplikatorjev kožnega nanosa 12 aplikatorjev kožnega nanosa 24 aplikatorjev kožnega nanosa
One application prevents flea infestation for one month. 
En nanos zdravila preprečuje okužbo z bolhami en mesec.
How to apply: Remove the spot-on applicator from the pack. 
Navodilo za nanos: Aplikator odstranite iz ovojnine.
Flea 
KARENCA
No important adverse reactions were observed in healthy kittens aged 7 weeks or more, topically treated 7 times at 2 week intervals and with up to 4 times the highest recommended dose except transient oedema or dry skin at the application site. 
Pri dajanju do 4-krat večjega odmerka od priporočenega, topikalno, 7-krat v dvotedenskih razmikih, ni bilo pri zdravih mačjih mladičih, starejših od 7 tednov, opaziti pomembnih neželenih učinkov, razen prehodnega edema ali suhe kože na mestu nanosa.
The treatment dose range is 42.3 to 705 mg dinotefuran/kg bodyweight and 4.23 to 70.5 mg pyriproxyfen/kg bodyweight for cats which weigh between 0.6 kg and 10 kg). 
Razpon odmerka je od 42,3 do 705 mg dinotefurana/kg telesne mase in od 4,23 do 70,5 mg piriproksifena/kg telesne mase za mačke od 0,6 kg do 10 kg telesne mase.)
The treatment dose range is 42.3 to 705 mg dinotefuran/kg bodyweight (bw) and 4.23 to 70.5 mg pyriproxyfen/kg bodyweight (bw) for cats of 0.6 kg to 10 kg bodyweight. 
Razpon odmerka je od 42,3 do 705 mg dinotefurana/kg telesne mase in od 4,23 do 70,5 mg piriproksifena/kg telesne mase za mačke od 0,6 kg do 10 kg telesne mase.
NAME OF THE VETERINARY MEDICINAL PRODUCT Vectra Felis 423 mg/42.3 mg spot-on solution for cats 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Vectra Felis 423 mg/42,3 mg kožni nanos, raztopina za mačke
• If the veterinary medicinal product accidentally gets into the eyes, they should be rinsed with water immediately, with the eyelids open, and for a sufficient length of time. 
• V primeru nenamernega stika z očmi, jih takoj sperite z vodo, pri čemer držite veke odprte in spirajte dovolj dolgo.Stiku z zdravljeno živaljo se izogibajte vsaj osem ur po nanosu zdravila.
The minimum recommended dose is 42.3 mg dinotefuran/kg bodyweight and 4.23 mg pyriproxyfen/kg bodyweight. 
Najnižji priporočeni odmerek je 42,3 mg dinotefurana/kg telesne mase in 4,23 mg piriproksifena/kg telesne mase.
The actives act directly on the cat's coat without any need to infiltrate the blood flow. 
Prehod učinkovin v krvni obtok ni potreben, saj delujeta neposredno na mačji dlaki.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS Each 0.9 ml spot-on applicator delivers: 423 mg dinotefuran and 42.3 mg pyriproxyfen. 
NAVEDBA UČINKOVIN(E) IN DRUGE(IH) SESTAVIN Vsak 0,9 ml aplikator kožnega nanosa vsebuje: 423 mg dinotefurana in 42,3 mg piriproksifena.
STATEMENT OF ACTIVE SUBSTANCES Each 0.9 ml spot-on applicator contains dinotefuran 423 mg and pyriproxyfen 42.3 mg. 
NAVEDBA UČINKOVIN Vsak 0,9 ml aplikator kožnega nanosa vsebuje dinotefuran 423 mg in piriproksifen 42,3 mg.
Insects do not have to ingest dinotefuran, it kills by contact. 
Dinotefuran ubije s stikom in ga insektu ni treba zaužiti.
PACKAGE LEAFLET: Vectra Felis 423 mg/42.3 mg spot-on solution for cats 
NAVODILO ZA UPORABO Vectra Felis 423 mg/42,3 mg kožni nanos, raztopina za mačke
QUANTITY OF THE ACTIVE SUBSTANCE(S) Each 0.9 ml spot-on applicator contains dinotefuran 423 mg and pyriproxyfen 42.3 mg. 
KOLIČINA UČINKOVIN(E) Vsak 0,9 ml aplikator kožnega nanosa vsebuje 423 mg dinotefurana in 42,3 mg piriproksifena.
[Text for pictogram] 
[Besedilo za piktogram]
• Drink the whole contents of the glass. 
• Popijte celotno vsebino kozarca.
First Opening: 
Prvo odprtje:
Date of first authorisation: 26 August 2011 Date of latest renewal: 28 April 2016 
Datum prve odobritve: 26. avgust 2011 Datum zadnjega podaljšanja: 28. april 2016
The tablets can be divided into equal halves. 
Tablete se lahko delijo na enake polovice.
Then CLcr is adjusted for body surface area (BSA) as follows: 
CLcr je prilagojen na telesno površino (BSA-»body surface area«) na sledeč način:
• Close the bottle with the plastic screw cap after every usage. 
• Zaprite steklenico s plastično navojno zaporko po vsaki uporabi.
Component of a multipack, can't be sold separately 
Del skupnega pakiranja, ni mogoče prodati ločeno.
For this the piston must be completely pushed into the syringe 
Za to mora biti bat do konca pritisnjen v brizgo
Do not use after 4 months of first opening the bottle. 
Ne uporabljajte več kot 4 mesece po prvem odprtju steklenice.
This decrease is more pronounced during the third trimester (up to 60 % of baseline concentration before pregnancy). 
To zmanjšanje koncentracije je bolj izrazito v tretjem trimesečju (do 60 % glede na običajno koncentracijo pred nosečnostjo).
6-48 months 
6-48 mesecev
Levetiracetam ratiopharm must be taken twice a day, once in the morning and once in the evening, at about the same time each day. 
Zdravilo Levetiracetam ratiopharm morate jemati dvakrat na dan, enkrat zjutraj in enkrat zvečer, vsak dan ob približno istem času.
Physiological changes during pregnancy may affect levetiracetam concentration. 
Fiziološke spremembe med nosečnostjo vplivajo na koncentracijo levetiracetama.
Read all of this leaflet carefully before you or your child start taking this medicine because it contains important information for you. 
Pred začetkom jemanja zdravila vi ali vaš otrok natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
• Take the syringe and put it in the opening of the bottle. 
• Vzemite brizgo in jo dajte v odprtino steklenice.
He/she may decide if your dose should be adjusted. 
Le ta se odloči, če je vaš odmerek potrebno prilagoditi.
• Remove the filled syringe from the bottle (figure ). 
• Odstranite napolnjeno brizgo iz steklenice (slika ).
EXP Do not use after 4 months of first opening the bottle. 
EXP Ne uporabljajte več kot 4 mesece po prvem odprtju steklenice.
Levetiracetam ratiopharm may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy. 
Zdravilo Levetiracetam ratiopharm lahko oslabi vašo sposobnost vožnje ali upravljanja z orodjem ali stroji, saj lahko povzroči zaspanost.
1-6 months 
1-6 mesecev
Patients are advised not to drive or use machines until it is established that their ability to perform such activities is not affected. 
Bolnikom svetujemo, naj ne vozijo ali upravljajo s stroji, dokler ni potrjeno, da zdravilo ne vpliva na njihovo sposobnost izvajanja teh dejavnosti.
This medicine contains 1.2 mmol (or 46.65 mg) potassium per 15 ml. 
To zdravilo vsebuje 1,2 mmol (ali 46,65 mg) kalija na 15 ml.
You should not drive or use machines until it is established that your ability to perform such activities is not affected. 
Ne smete voziti ali upravljati s stroji, dokler ni potrjeno, da zdravilo ne vpliva na vašo sposobnost izvajanja teh dejavnosti.
• Fill the syringe with the liquid by pulling the piston to the graduation mark corresponding to the quantity in millilitre (ml) prescribed by your doctor. 
• Napolnite brizgo s tekočino, tako da vlečete bat navzdol do oznake, ki ustreza količini v mililitrih (ml), ki vam jo je predpisal zdravnik.